nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine—SLC22A5—Dactinomycin—muscle cancer	0.0906	0.109	CbGbCtD
Quinidine—ABCB11—Vincristine—muscle cancer	0.0826	0.0991	CbGbCtD
Quinidine—CYP1A1—Dacarbazine—muscle cancer	0.0679	0.0815	CbGbCtD
Quinidine—CYP2E1—Dacarbazine—muscle cancer	0.0524	0.0629	CbGbCtD
Quinidine—ABCB11—Doxorubicin—muscle cancer	0.0516	0.0619	CbGbCtD
Quinidine—ABCC2—Vincristine—muscle cancer	0.0434	0.0521	CbGbCtD
Quinidine—ABCC2—Etoposide—muscle cancer	0.0398	0.0478	CbGbCtD
Quinidine—SLCO1A2—Methotrexate—muscle cancer	0.0317	0.0381	CbGbCtD
Quinidine—CYP1A2—Dacarbazine—muscle cancer	0.0303	0.0364	CbGbCtD
Quinidine—SLCO1B1—Methotrexate—muscle cancer	0.0299	0.0359	CbGbCtD
Quinidine—CYP3A7—Vincristine—muscle cancer	0.029	0.0348	CbGbCtD
Quinidine—CYP3A7-CYP3A51P—Vincristine—muscle cancer	0.029	0.0348	CbGbCtD
Quinidine—SLC22A8—Methotrexate—muscle cancer	0.0276	0.0331	CbGbCtD
Quinidine—ABCC2—Doxorubicin—muscle cancer	0.0271	0.0326	CbGbCtD
Quinidine—ABCC2—Methotrexate—muscle cancer	0.0263	0.0316	CbGbCtD
Quinidine—CYP2E1—Etoposide—muscle cancer	0.0257	0.0308	CbGbCtD
Quinidine—ABCB1—Dactinomycin—muscle cancer	0.023	0.0276	CbGbCtD
Quinidine—CYP2C8—Etoposide—muscle cancer	0.0192	0.023	CbGbCtD
Quinidine—CYP2B6—Doxorubicin—muscle cancer	0.0173	0.0207	CbGbCtD
Quinidine—CYP1A2—Etoposide—muscle cancer	0.0148	0.0178	CbGbCtD
Quinidine—ABCB1—Vincristine—muscle cancer	0.0142	0.017	CbGbCtD
Quinidine—ABCB1—Etoposide—muscle cancer	0.013	0.0156	CbGbCtD
Quinidine—ABCB1—Doxorubicin—muscle cancer	0.00885	0.0106	CbGbCtD
Quinidine—ABCB1—Methotrexate—muscle cancer	0.00857	0.0103	CbGbCtD
Quinidine—CYP3A4—Vincristine—muscle cancer	0.00848	0.0102	CbGbCtD
Quinidine—CYP2D6—Doxorubicin—muscle cancer	0.00834	0.01	CbGbCtD
Quinidine—CYP3A4—Etoposide—muscle cancer	0.00777	0.00933	CbGbCtD
Quinidine—CYP3A4—Doxorubicin—muscle cancer	0.0053	0.00636	CbGbCtD
Quinidine—SLC22A4—larynx—muscle cancer	0.00484	0.0936	CbGeAlD
Quinidine—KCNK6—head—muscle cancer	0.00233	0.0451	CbGeAlD
Quinidine—KCNK6—testis—muscle cancer	0.00225	0.0436	CbGeAlD
Quinidine—KCNK1—renal system—muscle cancer	0.00154	0.0299	CbGeAlD
Quinidine—KCNK1—cardiac atrium—muscle cancer	0.00138	0.0267	CbGeAlD
Quinidine—KCNK1—tendon—muscle cancer	0.0012	0.0233	CbGeAlD
Quinidine—KCNK1—vagina—muscle cancer	0.00112	0.0216	CbGeAlD
Quinidine—SLC22A2—renal system—muscle cancer	0.00109	0.0211	CbGeAlD
Quinidine—KCNK1—head—muscle cancer	0.00103	0.02	CbGeAlD
Quinidine—KCNK1—testis—muscle cancer	0.000997	0.0193	CbGeAlD
Quinidine—SCN3A—renal system—muscle cancer	0.000924	0.0179	CbGeAlD
Quinidine—SLCO1B1—renal system—muscle cancer	0.000912	0.0176	CbGeAlD
Quinidine—ABCB11—testis—muscle cancer	0.000879	0.017	CbGeAlD
Quinidine—SCN5A—cardiac atrium—muscle cancer	0.000825	0.016	CbGeAlD
Quinidine—SLC22A4—renal system—muscle cancer	0.000809	0.0157	CbGeAlD
Quinidine—SLC22A1—renal system—muscle cancer	0.000771	0.0149	CbGeAlD
Quinidine—SCN1A—head—muscle cancer	0.000767	0.0148	CbGeAlD
Quinidine—SCN2A—vagina—muscle cancer	0.000762	0.0147	CbGeAlD
Quinidine—SLCO1A2—renal system—muscle cancer	0.000742	0.0144	CbGeAlD
Quinidine—SCN3A—tendon—muscle cancer	0.000722	0.014	CbGeAlD
Quinidine—SLC22A8—renal system—muscle cancer	0.000709	0.0137	CbGeAlD
Quinidine—SCN2A—head—muscle cancer	0.000704	0.0136	CbGeAlD
Quinidine—SCN3A—bone marrow—muscle cancer	0.000699	0.0135	CbGeAlD
Quinidine—ABCC2—renal system—muscle cancer	0.000691	0.0134	CbGeAlD
Quinidine—SCN3A—vagina—muscle cancer	0.00067	0.013	CbGeAlD
Quinidine—SCN5A—vagina—muscle cancer	0.000668	0.0129	CbGeAlD
Quinidine—ORM1—bone marrow—muscle cancer	0.000636	0.0123	CbGeAlD
Quinidine—SLC22A4—tendon—muscle cancer	0.000632	0.0122	CbGeAlD
Quinidine—SCN3A—head—muscle cancer	0.000618	0.012	CbGeAlD
Quinidine—SCN5A—head—muscle cancer	0.000617	0.0119	CbGeAlD
Quinidine—SLC22A4—bone marrow—muscle cancer	0.000612	0.0118	CbGeAlD
Quinidine—SCN3A—testis—muscle cancer	0.000597	0.0116	CbGeAlD
Quinidine—SLC22A4—vagina—muscle cancer	0.000586	0.0113	CbGeAlD
Quinidine—KCNH2—renal system—muscle cancer	0.000567	0.011	CbGeAlD
Quinidine—SLC22A1—vagina—muscle cancer	0.000558	0.0108	CbGeAlD
Quinidine—ABCC2—tendon—muscle cancer	0.00054	0.0104	CbGeAlD
Quinidine—SLC22A5—renal system—muscle cancer	0.000536	0.0104	CbGeAlD
Quinidine—CHRM2—head—muscle cancer	0.000525	0.0102	CbGeAlD
Quinidine—CYP2C8—renal system—muscle cancer	0.000519	0.01	CbGeAlD
Quinidine—SLC22A1—head—muscle cancer	0.000516	0.00998	CbGeAlD
Quinidine—KCNH2—cardiac atrium—muscle cancer	0.000508	0.00982	CbGeAlD
Quinidine—SLCO1A2—head—muscle cancer	0.000497	0.00961	CbGeAlD
Quinidine—CYP1A2—renal system—muscle cancer	0.000485	0.00939	CbGeAlD
Quinidine—SLCO1A2—testis—muscle cancer	0.00048	0.00928	CbGeAlD
Quinidine—SLC22A5—cardiac atrium—muscle cancer	0.00048	0.00928	CbGeAlD
Quinidine—CYP1A1—renal system—muscle cancer	0.000479	0.00926	CbGeAlD
Quinidine—SLC22A8—head—muscle cancer	0.000474	0.00917	CbGeAlD
Quinidine—CYP2B6—renal system—muscle cancer	0.000465	0.009	CbGeAlD
Quinidine—ABCC2—testis—muscle cancer	0.000447	0.00865	CbGeAlD
Quinidine—Mediastinal disorder—Vincristine—muscle cancer	0.000445	0.00387	CcSEcCtD
Quinidine—Stevens-Johnson syndrome—Etoposide—muscle cancer	0.000442	0.00385	CcSEcCtD
Quinidine—Renal failure—Etoposide—muscle cancer	0.000438	0.00381	CcSEcCtD
Quinidine—CYP2E1—renal system—muscle cancer	0.000436	0.00845	CbGeAlD
Quinidine—Coma—Methotrexate—muscle cancer	0.000436	0.0038	CcSEcCtD
Quinidine—Jaundice—Etoposide—muscle cancer	0.000434	0.00378	CcSEcCtD
Quinidine—Mental disorder—Vincristine—muscle cancer	0.000432	0.00377	CcSEcCtD
Quinidine—Ecchymosis—Methotrexate—muscle cancer	0.000431	0.00376	CcSEcCtD
Quinidine—Leukopenia—Dactinomycin—muscle cancer	0.00043	0.00375	CcSEcCtD
Quinidine—CYP1A1—cardiac atrium—muscle cancer	0.000429	0.0083	CbGeAlD
Quinidine—KCNH2—bone marrow—muscle cancer	0.000428	0.00829	CbGeAlD
Quinidine—Atrioventricular block—Doxorubicin—muscle cancer	0.000426	0.00371	CcSEcCtD
Quinidine—Pulmonary oedema—Methotrexate—muscle cancer	0.000424	0.0037	CcSEcCtD
Quinidine—SLC22A5—tendon—muscle cancer	0.000418	0.00809	CbGeAlD
Quinidine—Agranulocytosis—Etoposide—muscle cancer	0.000416	0.00362	CcSEcCtD
Quinidine—Ventricular tachycardia—Doxorubicin—muscle cancer	0.000413	0.0036	CcSEcCtD
Quinidine—KCNH2—vagina—muscle cancer	0.00041	0.00794	CbGeAlD
Quinidine—Myalgia—Dactinomycin—muscle cancer	0.000409	0.00357	CcSEcCtD
Quinidine—Dermatitis contact—Doxorubicin—muscle cancer	0.000408	0.00355	CcSEcCtD
Quinidine—Urinary tract disorder—Etoposide—muscle cancer	0.000395	0.00344	CcSEcCtD
Quinidine—Agitation—Vincristine—muscle cancer	0.000395	0.00344	CcSEcCtD
Quinidine—Photosensitivity—Methotrexate—muscle cancer	0.000394	0.00343	CcSEcCtD
Quinidine—Oedema—Dactinomycin—muscle cancer	0.000392	0.00342	CcSEcCtD
Quinidine—Urethral disorder—Etoposide—muscle cancer	0.000392	0.00341	CcSEcCtD
Quinidine—SLC22A5—vagina—muscle cancer	0.000388	0.00751	CbGeAlD
Quinidine—Aplastic anaemia—Doxorubicin—muscle cancer	0.000388	0.00338	CcSEcCtD
Quinidine—Vertigo—Vincristine—muscle cancer	0.000386	0.00336	CcSEcCtD
Quinidine—Leukopenia—Vincristine—muscle cancer	0.000385	0.00335	CcSEcCtD
Quinidine—Thrombocytopenia—Dactinomycin—muscle cancer	0.000384	0.00335	CcSEcCtD
Quinidine—KCNH2—head—muscle cancer	0.000379	0.00734	CbGeAlD
Quinidine—Erythema multiforme—Etoposide—muscle cancer	0.000378	0.00329	CcSEcCtD
Quinidine—Coma—Doxorubicin—muscle cancer	0.000377	0.00329	CcSEcCtD
Quinidine—Oesophagitis—Doxorubicin—muscle cancer	0.000377	0.00329	CcSEcCtD
Quinidine—CYP2C8—vagina—muscle cancer	0.000376	0.00727	CbGeAlD
Quinidine—Renal failure acute—Methotrexate—muscle cancer	0.000375	0.00327	CcSEcCtD
Quinidine—Anorexia—Dactinomycin—muscle cancer	0.000374	0.00326	CcSEcCtD
Quinidine—Eye disorder—Etoposide—muscle cancer	0.000374	0.00325	CcSEcCtD
Quinidine—Ecchymosis—Doxorubicin—muscle cancer	0.000373	0.00325	CcSEcCtD
Quinidine—Convulsion—Vincristine—muscle cancer	0.000372	0.00324	CcSEcCtD
Quinidine—Cardiac disorder—Etoposide—muscle cancer	0.000371	0.00323	CcSEcCtD
Quinidine—Flushing—Etoposide—muscle cancer	0.000371	0.00323	CcSEcCtD
Quinidine—Pulmonary oedema—Doxorubicin—muscle cancer	0.000368	0.0032	CcSEcCtD
Quinidine—Dermatitis exfoliative—Methotrexate—muscle cancer	0.000367	0.0032	CcSEcCtD
Quinidine—KCNH2—testis—muscle cancer	0.000366	0.00709	CbGeAlD
Quinidine—Myalgia—Vincristine—muscle cancer	0.000366	0.00319	CcSEcCtD
Quinidine—Visual disturbance—Methotrexate—muscle cancer	0.000365	0.00318	CcSEcCtD
Quinidine—Immune system disorder—Etoposide—muscle cancer	0.000361	0.00315	CcSEcCtD
Quinidine—Mediastinal disorder—Etoposide—muscle cancer	0.00036	0.00314	CcSEcCtD
Quinidine—Chills—Etoposide—muscle cancer	0.000359	0.00312	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000358	0.00311	CcSEcCtD
Quinidine—CYP3A4—renal system—muscle cancer	0.000351	0.0068	CbGeAlD
Quinidine—Oedema—Vincristine—muscle cancer	0.000351	0.00305	CcSEcCtD
Quinidine—CYP1A1—vagina—muscle cancer	0.000347	0.00671	CbGeAlD
Quinidine—SLC22A5—testis—muscle cancer	0.000346	0.0067	CbGeAlD
Quinidine—CYP2D6—renal system—muscle cancer	0.000346	0.00669	CbGeAlD
Quinidine—Nervous system disorder—Vincristine—muscle cancer	0.000344	0.00299	CcSEcCtD
Quinidine—Thrombocytopenia—Vincristine—muscle cancer	0.000343	0.00299	CcSEcCtD
Quinidine—Photosensitivity—Doxorubicin—muscle cancer	0.000341	0.00297	CcSEcCtD
Quinidine—Decreased appetite—Dactinomycin—muscle cancer	0.000341	0.00297	CcSEcCtD
Quinidine—CYP2E1—tendon—muscle cancer	0.000341	0.00659	CbGeAlD
Quinidine—Hyperhidrosis—Vincristine—muscle cancer	0.000339	0.00295	CcSEcCtD
Quinidine—CYP2B6—vagina—muscle cancer	0.000337	0.00652	CbGeAlD
Quinidine—CYP2C8—testis—muscle cancer	0.000335	0.00649	CbGeAlD
Quinidine—Anorexia—Vincristine—muscle cancer	0.000334	0.00291	CcSEcCtD
Quinidine—Eczema—Doxorubicin—muscle cancer	0.000334	0.0029	CcSEcCtD
Quinidine—ABCB1—embryo—muscle cancer	0.000328	0.00636	CbGeAlD
Quinidine—Hypotension—Vincristine—muscle cancer	0.000328	0.00285	CcSEcCtD
Quinidine—Ataxia—Methotrexate—muscle cancer	0.000326	0.00283	CcSEcCtD
Quinidine—Renal failure acute—Doxorubicin—muscle cancer	0.000325	0.00283	CcSEcCtD
Quinidine—Feeling abnormal—Dactinomycin—muscle cancer	0.000323	0.00282	CcSEcCtD
Quinidine—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000321	0.0028	CcSEcCtD
Quinidine—CYP1A1—head—muscle cancer	0.00032	0.0062	CbGeAlD
Quinidine—Liver function test abnormal—Methotrexate—muscle cancer	0.00032	0.00278	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000319	0.00278	CcSEcCtD
Quinidine—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.000318	0.00277	CcSEcCtD
Quinidine—Renal impairment—Doxorubicin—muscle cancer	0.000315	0.00274	CcSEcCtD
Quinidine—Dermatitis bullous—Doxorubicin—muscle cancer	0.000314	0.00273	CcSEcCtD
Quinidine—Breast disorder—Methotrexate—muscle cancer	0.000313	0.00272	CcSEcCtD
Quinidine—Vertigo—Etoposide—muscle cancer	0.000313	0.00272	CcSEcCtD
Quinidine—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.000312	0.00271	CcSEcCtD
Quinidine—Leukopenia—Etoposide—muscle cancer	0.000312	0.00271	CcSEcCtD
Quinidine—CYP2B6—head—muscle cancer	0.000311	0.00602	CbGeAlD
Quinidine—Purpura—Doxorubicin—muscle cancer	0.000311	0.00271	CcSEcCtD
Quinidine—Abdominal pain—Dactinomycin—muscle cancer	0.00031	0.0027	CcSEcCtD
Quinidine—Body temperature increased—Dactinomycin—muscle cancer	0.00031	0.0027	CcSEcCtD
Quinidine—Hypoglycaemia—Doxorubicin—muscle cancer	0.000307	0.00268	CcSEcCtD
Quinidine—Loss of consciousness—Etoposide—muscle cancer	0.000306	0.00266	CcSEcCtD
Quinidine—Decreased appetite—Vincristine—muscle cancer	0.000305	0.00265	CcSEcCtD
Quinidine—Gastrointestinal disorder—Vincristine—muscle cancer	0.000303	0.00264	CcSEcCtD
Quinidine—Convulsion—Etoposide—muscle cancer	0.000302	0.00263	CcSEcCtD
Quinidine—CYP2B6—testis—muscle cancer	0.000301	0.00582	CbGeAlD
Quinidine—Diplopia—Doxorubicin—muscle cancer	0.0003	0.00261	CcSEcCtD
Quinidine—Asthma—Methotrexate—muscle cancer	0.000299	0.00261	CcSEcCtD
Quinidine—Chest pain—Etoposide—muscle cancer	0.000296	0.00258	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000294	0.00256	CcSEcCtD
Quinidine—CYP2E1—head—muscle cancer	0.000292	0.00565	CbGeAlD
Quinidine—Hypersensitivity—Dactinomycin—muscle cancer	0.000289	0.00252	CcSEcCtD
Quinidine—Gastrointestinal pain—Vincristine—muscle cancer	0.000287	0.0025	CcSEcCtD
Quinidine—Confusional state—Etoposide—muscle cancer	0.000286	0.00249	CcSEcCtD
Quinidine—Cardiac arrest—Doxorubicin—muscle cancer	0.000285	0.00248	CcSEcCtD
Quinidine—Pancytopenia—Methotrexate—muscle cancer	0.000284	0.00247	CcSEcCtD
Quinidine—CYP2E1—testis—muscle cancer	0.000282	0.00546	CbGeAlD
Quinidine—Ataxia—Doxorubicin—muscle cancer	0.000282	0.00245	CcSEcCtD
Quinidine—Asthenia—Dactinomycin—muscle cancer	0.000282	0.00245	CcSEcCtD
Quinidine—Neutropenia—Methotrexate—muscle cancer	0.00028	0.00244	CcSEcCtD
Quinidine—Thrombocytopenia—Etoposide—muscle cancer	0.000278	0.00242	CcSEcCtD
Quinidine—Tachycardia—Etoposide—muscle cancer	0.000277	0.00241	CcSEcCtD
Quinidine—Body temperature increased—Vincristine—muscle cancer	0.000277	0.00241	CcSEcCtD
Quinidine—Abdominal pain—Vincristine—muscle cancer	0.000277	0.00241	CcSEcCtD
Quinidine—Liver function test abnormal—Doxorubicin—muscle cancer	0.000277	0.00241	CcSEcCtD
Quinidine—Skin disorder—Etoposide—muscle cancer	0.000276	0.0024	CcSEcCtD
Quinidine—Hyperhidrosis—Etoposide—muscle cancer	0.000275	0.00239	CcSEcCtD
Quinidine—Abdominal pain upper—Doxorubicin—muscle cancer	0.000274	0.00238	CcSEcCtD
Quinidine—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000274	0.00238	CcSEcCtD
Quinidine—Photosensitivity reaction—Methotrexate—muscle cancer	0.000273	0.00238	CcSEcCtD
Quinidine—Breast disorder—Doxorubicin—muscle cancer	0.000271	0.00236	CcSEcCtD
Quinidine—Anorexia—Etoposide—muscle cancer	0.000271	0.00236	CcSEcCtD
Quinidine—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.00027	0.00235	CcSEcCtD
Quinidine—Diarrhoea—Dactinomycin—muscle cancer	0.000269	0.00234	CcSEcCtD
Quinidine—Hypotension—Etoposide—muscle cancer	0.000265	0.00231	CcSEcCtD
Quinidine—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000264	0.0023	CcSEcCtD
Quinidine—Muscular weakness—Doxorubicin—muscle cancer	0.000264	0.0023	CcSEcCtD
Quinidine—Renal failure—Methotrexate—muscle cancer	0.000262	0.00228	CcSEcCtD
Quinidine—Asthma—Doxorubicin—muscle cancer	0.000259	0.00226	CcSEcCtD
Quinidine—Hypersensitivity—Vincristine—muscle cancer	0.000258	0.00225	CcSEcCtD
Quinidine—Sweating—Methotrexate—muscle cancer	0.000256	0.00223	CcSEcCtD
Quinidine—Dyspnoea—Etoposide—muscle cancer	0.000253	0.00221	CcSEcCtD
Quinidine—Angina pectoris—Doxorubicin—muscle cancer	0.000252	0.0022	CcSEcCtD
Quinidine—Asthenia—Vincristine—muscle cancer	0.000252	0.00219	CcSEcCtD
Quinidine—Vomiting—Dactinomycin—muscle cancer	0.00025	0.00217	CcSEcCtD
Quinidine—Agranulocytosis—Methotrexate—muscle cancer	0.000249	0.00217	CcSEcCtD
Quinidine—ABCB1—renal system—muscle cancer	0.000249	0.00481	CbGeAlD
Quinidine—Rash—Dactinomycin—muscle cancer	0.000247	0.00216	CcSEcCtD
Quinidine—Decreased appetite—Etoposide—muscle cancer	0.000247	0.00215	CcSEcCtD
Quinidine—Pancytopenia—Doxorubicin—muscle cancer	0.000246	0.00214	CcSEcCtD
Quinidine—Gastrointestinal disorder—Etoposide—muscle cancer	0.000245	0.00214	CcSEcCtD
Quinidine—Neutropenia—Doxorubicin—muscle cancer	0.000242	0.00211	CcSEcCtD
Quinidine—Haemoglobin—Methotrexate—muscle cancer	0.000241	0.0021	CcSEcCtD
Quinidine—Diarrhoea—Vincristine—muscle cancer	0.00024	0.00209	CcSEcCtD
Quinidine—Haemorrhage—Methotrexate—muscle cancer	0.000239	0.00209	CcSEcCtD
Quinidine—Hepatitis—Methotrexate—muscle cancer	0.000239	0.00209	CcSEcCtD
Quinidine—Urinary tract disorder—Methotrexate—muscle cancer	0.000237	0.00206	CcSEcCtD
Quinidine—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000236	0.00206	CcSEcCtD
Quinidine—Urethral disorder—Methotrexate—muscle cancer	0.000235	0.00204	CcSEcCtD
Quinidine—Feeling abnormal—Etoposide—muscle cancer	0.000234	0.00204	CcSEcCtD
Quinidine—Nausea—Dactinomycin—muscle cancer	0.000233	0.00203	CcSEcCtD
Quinidine—Gastrointestinal pain—Etoposide—muscle cancer	0.000232	0.00202	CcSEcCtD
Quinidine—Dizziness—Vincristine—muscle cancer	0.000232	0.00202	CcSEcCtD
Quinidine—CYP2D6—head—muscle cancer	0.000231	0.00447	CbGeAlD
Quinidine—Visual impairment—Methotrexate—muscle cancer	0.000231	0.00201	CcSEcCtD
Quinidine—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000229	0.00199	CcSEcCtD
Quinidine—Renal failure—Doxorubicin—muscle cancer	0.000227	0.00198	CcSEcCtD
Quinidine—Erythema multiforme—Methotrexate—muscle cancer	0.000226	0.00197	CcSEcCtD
Quinidine—Urticaria—Etoposide—muscle cancer	0.000226	0.00197	CcSEcCtD
Quinidine—Jaundice—Doxorubicin—muscle cancer	0.000225	0.00196	CcSEcCtD
Quinidine—Body temperature increased—Etoposide—muscle cancer	0.000225	0.00196	CcSEcCtD
Quinidine—Abdominal pain—Etoposide—muscle cancer	0.000225	0.00196	CcSEcCtD
Quinidine—Eye disorder—Methotrexate—muscle cancer	0.000224	0.00195	CcSEcCtD
Quinidine—CYP2D6—testis—muscle cancer	0.000223	0.00432	CbGeAlD
Quinidine—Tinnitus—Methotrexate—muscle cancer	0.000223	0.00194	CcSEcCtD
Quinidine—Vomiting—Vincristine—muscle cancer	0.000223	0.00194	CcSEcCtD
Quinidine—Cardiac disorder—Methotrexate—muscle cancer	0.000222	0.00194	CcSEcCtD
Quinidine—Sweating—Doxorubicin—muscle cancer	0.000221	0.00193	CcSEcCtD
Quinidine—Rash—Vincristine—muscle cancer	0.000221	0.00193	CcSEcCtD
Quinidine—Dermatitis—Vincristine—muscle cancer	0.000221	0.00192	CcSEcCtD
Quinidine—Headache—Vincristine—muscle cancer	0.00022	0.00191	CcSEcCtD
Quinidine—Immune system disorder—Methotrexate—muscle cancer	0.000216	0.00188	CcSEcCtD
Quinidine—Mediastinal disorder—Methotrexate—muscle cancer	0.000216	0.00188	CcSEcCtD
Quinidine—Agranulocytosis—Doxorubicin—muscle cancer	0.000216	0.00188	CcSEcCtD
Quinidine—Chills—Methotrexate—muscle cancer	0.000215	0.00187	CcSEcCtD
Quinidine—Bradycardia—Doxorubicin—muscle cancer	0.000211	0.00184	CcSEcCtD
Quinidine—Mental disorder—Methotrexate—muscle cancer	0.00021	0.00183	CcSEcCtD
Quinidine—Hypersensitivity—Etoposide—muscle cancer	0.000209	0.00182	CcSEcCtD
Quinidine—Erythema—Methotrexate—muscle cancer	0.000208	0.00182	CcSEcCtD
Quinidine—Malnutrition—Methotrexate—muscle cancer	0.000208	0.00182	CcSEcCtD
Quinidine—Haemoglobin—Doxorubicin—muscle cancer	0.000208	0.00182	CcSEcCtD
Quinidine—Nausea—Vincristine—muscle cancer	0.000208	0.00181	CcSEcCtD
Quinidine—Haemorrhage—Doxorubicin—muscle cancer	0.000207	0.00181	CcSEcCtD
Quinidine—Hepatitis—Doxorubicin—muscle cancer	0.000207	0.00181	CcSEcCtD
Quinidine—Urinary tract disorder—Doxorubicin—muscle cancer	0.000205	0.00178	CcSEcCtD
Quinidine—Asthenia—Etoposide—muscle cancer	0.000204	0.00177	CcSEcCtD
Quinidine—Urethral disorder—Doxorubicin—muscle cancer	0.000203	0.00177	CcSEcCtD
Quinidine—Pruritus—Etoposide—muscle cancer	0.000201	0.00175	CcSEcCtD
Quinidine—Visual impairment—Doxorubicin—muscle cancer	0.0002	0.00174	CcSEcCtD
Quinidine—Vision blurred—Methotrexate—muscle cancer	0.000196	0.00171	CcSEcCtD
Quinidine—Erythema multiforme—Doxorubicin—muscle cancer	0.000196	0.00171	CcSEcCtD
Quinidine—Diarrhoea—Etoposide—muscle cancer	0.000194	0.00169	CcSEcCtD
Quinidine—Eye disorder—Doxorubicin—muscle cancer	0.000194	0.00169	CcSEcCtD
Quinidine—Tinnitus—Doxorubicin—muscle cancer	0.000193	0.00168	CcSEcCtD
Quinidine—Flushing—Doxorubicin—muscle cancer	0.000192	0.00168	CcSEcCtD
Quinidine—Cardiac disorder—Doxorubicin—muscle cancer	0.000192	0.00168	CcSEcCtD
Quinidine—ABCB1—bone marrow—muscle cancer	0.000188	0.00364	CbGeAlD
Quinidine—Dizziness—Etoposide—muscle cancer	0.000188	0.00164	CcSEcCtD
Quinidine—Immune system disorder—Doxorubicin—muscle cancer	0.000187	0.00163	CcSEcCtD
Quinidine—Vertigo—Methotrexate—muscle cancer	0.000187	0.00163	CcSEcCtD
Quinidine—Mediastinal disorder—Doxorubicin—muscle cancer	0.000187	0.00163	CcSEcCtD
Quinidine—Leukopenia—Methotrexate—muscle cancer	0.000187	0.00163	CcSEcCtD
Quinidine—Chills—Doxorubicin—muscle cancer	0.000186	0.00162	CcSEcCtD
Quinidine—Mental disorder—Doxorubicin—muscle cancer	0.000182	0.00158	CcSEcCtD
Quinidine—Convulsion—Methotrexate—muscle cancer	0.000181	0.00157	CcSEcCtD
Quinidine—Vomiting—Etoposide—muscle cancer	0.000181	0.00157	CcSEcCtD
Quinidine—Erythema—Doxorubicin—muscle cancer	0.000181	0.00157	CcSEcCtD
Quinidine—Malnutrition—Doxorubicin—muscle cancer	0.000181	0.00157	CcSEcCtD
Quinidine—ABCB1—vagina—muscle cancer	0.00018	0.00348	CbGeAlD
Quinidine—Rash—Etoposide—muscle cancer	0.000179	0.00156	CcSEcCtD
Quinidine—Dermatitis—Etoposide—muscle cancer	0.000179	0.00156	CcSEcCtD
Quinidine—Headache—Etoposide—muscle cancer	0.000178	0.00155	CcSEcCtD
Quinidine—Myalgia—Methotrexate—muscle cancer	0.000177	0.00155	CcSEcCtD
Quinidine—Chest pain—Methotrexate—muscle cancer	0.000177	0.00155	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000176	0.00154	CcSEcCtD
Quinidine—Confusional state—Methotrexate—muscle cancer	0.000172	0.00149	CcSEcCtD
Quinidine—Vision blurred—Doxorubicin—muscle cancer	0.00017	0.00148	CcSEcCtD
Quinidine—Nausea—Etoposide—muscle cancer	0.000169	0.00147	CcSEcCtD
Quinidine—Nervous system disorder—Methotrexate—muscle cancer	0.000167	0.00145	CcSEcCtD
Quinidine—Thrombocytopenia—Methotrexate—muscle cancer	0.000167	0.00145	CcSEcCtD
Quinidine—ABCB1—head—muscle cancer	0.000166	0.00322	CbGeAlD
Quinidine—Agitation—Doxorubicin—muscle cancer	0.000166	0.00144	CcSEcCtD
Quinidine—Skin disorder—Methotrexate—muscle cancer	0.000165	0.00144	CcSEcCtD
Quinidine—Hyperhidrosis—Methotrexate—muscle cancer	0.000164	0.00143	CcSEcCtD
Quinidine—Vertigo—Doxorubicin—muscle cancer	0.000162	0.00141	CcSEcCtD
Quinidine—Anorexia—Methotrexate—muscle cancer	0.000162	0.00141	CcSEcCtD
Quinidine—Syncope—Doxorubicin—muscle cancer	0.000162	0.00141	CcSEcCtD
Quinidine—Leukopenia—Doxorubicin—muscle cancer	0.000162	0.00141	CcSEcCtD
Quinidine—ABCB1—testis—muscle cancer	0.000161	0.00311	CbGeAlD
Quinidine—Palpitations—Doxorubicin—muscle cancer	0.00016	0.00139	CcSEcCtD
Quinidine—Hypotension—Methotrexate—muscle cancer	0.000159	0.00138	CcSEcCtD
Quinidine—Loss of consciousness—Doxorubicin—muscle cancer	0.000159	0.00138	CcSEcCtD
Quinidine—Convulsion—Doxorubicin—muscle cancer	0.000156	0.00136	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000155	0.00135	CcSEcCtD
Quinidine—Myalgia—Doxorubicin—muscle cancer	0.000154	0.00134	CcSEcCtD
Quinidine—Chest pain—Doxorubicin—muscle cancer	0.000154	0.00134	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000153	0.00133	CcSEcCtD
Quinidine—Dyspnoea—Methotrexate—muscle cancer	0.000152	0.00132	CcSEcCtD
Quinidine—Confusional state—Doxorubicin—muscle cancer	0.000149	0.00129	CcSEcCtD
Quinidine—Decreased appetite—Methotrexate—muscle cancer	0.000148	0.00129	CcSEcCtD
Quinidine—Oedema—Doxorubicin—muscle cancer	0.000147	0.00128	CcSEcCtD
Quinidine—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000147	0.00128	CcSEcCtD
Quinidine—Shock—Doxorubicin—muscle cancer	0.000145	0.00126	CcSEcCtD
Quinidine—Nervous system disorder—Doxorubicin—muscle cancer	0.000144	0.00126	CcSEcCtD
Quinidine—Thrombocytopenia—Doxorubicin—muscle cancer	0.000144	0.00126	CcSEcCtD
Quinidine—Tachycardia—Doxorubicin—muscle cancer	0.000144	0.00125	CcSEcCtD
Quinidine—Skin disorder—Doxorubicin—muscle cancer	0.000143	0.00125	CcSEcCtD
Quinidine—Hyperhidrosis—Doxorubicin—muscle cancer	0.000142	0.00124	CcSEcCtD
Quinidine—Anorexia—Doxorubicin—muscle cancer	0.00014	0.00122	CcSEcCtD
Quinidine—Feeling abnormal—Methotrexate—muscle cancer	0.00014	0.00122	CcSEcCtD
Quinidine—Gastrointestinal pain—Methotrexate—muscle cancer	0.000139	0.00121	CcSEcCtD
Quinidine—Hypotension—Doxorubicin—muscle cancer	0.000138	0.0012	CcSEcCtD
Quinidine—Urticaria—Methotrexate—muscle cancer	0.000135	0.00118	CcSEcCtD
Quinidine—Body temperature increased—Methotrexate—muscle cancer	0.000135	0.00117	CcSEcCtD
Quinidine—Abdominal pain—Methotrexate—muscle cancer	0.000135	0.00117	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000134	0.00117	CcSEcCtD
Quinidine—Dyspnoea—Doxorubicin—muscle cancer	0.000131	0.00114	CcSEcCtD
Quinidine—Decreased appetite—Doxorubicin—muscle cancer	0.000128	0.00112	CcSEcCtD
Quinidine—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000127	0.00111	CcSEcCtD
Quinidine—Hypersensitivity—Methotrexate—muscle cancer	0.000125	0.00109	CcSEcCtD
Quinidine—Asthenia—Methotrexate—muscle cancer	0.000122	0.00106	CcSEcCtD
Quinidine—Feeling abnormal—Doxorubicin—muscle cancer	0.000121	0.00106	CcSEcCtD
Quinidine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00012	0.00105	CcSEcCtD
Quinidine—Pruritus—Methotrexate—muscle cancer	0.00012	0.00105	CcSEcCtD
Quinidine—Urticaria—Doxorubicin—muscle cancer	0.000117	0.00102	CcSEcCtD
Quinidine—Body temperature increased—Doxorubicin—muscle cancer	0.000116	0.00101	CcSEcCtD
Quinidine—Abdominal pain—Doxorubicin—muscle cancer	0.000116	0.00101	CcSEcCtD
Quinidine—Diarrhoea—Methotrexate—muscle cancer	0.000116	0.00101	CcSEcCtD
Quinidine—Dizziness—Methotrexate—muscle cancer	0.000113	0.00098	CcSEcCtD
Quinidine—Hypersensitivity—Doxorubicin—muscle cancer	0.000109	0.000945	CcSEcCtD
Quinidine—Vomiting—Methotrexate—muscle cancer	0.000108	0.000942	CcSEcCtD
Quinidine—Rash—Methotrexate—muscle cancer	0.000107	0.000934	CcSEcCtD
Quinidine—Dermatitis—Methotrexate—muscle cancer	0.000107	0.000933	CcSEcCtD
Quinidine—Headache—Methotrexate—muscle cancer	0.000107	0.000928	CcSEcCtD
Quinidine—Asthenia—Doxorubicin—muscle cancer	0.000106	0.000921	CcSEcCtD
Quinidine—Pruritus—Doxorubicin—muscle cancer	0.000104	0.000908	CcSEcCtD
Quinidine—Nausea—Methotrexate—muscle cancer	0.000101	0.00088	CcSEcCtD
Quinidine—Diarrhoea—Doxorubicin—muscle cancer	0.000101	0.000878	CcSEcCtD
Quinidine—Dizziness—Doxorubicin—muscle cancer	9.74e-05	0.000848	CcSEcCtD
Quinidine—Vomiting—Doxorubicin—muscle cancer	9.37e-05	0.000816	CcSEcCtD
Quinidine—Rash—Doxorubicin—muscle cancer	9.29e-05	0.000809	CcSEcCtD
Quinidine—Dermatitis—Doxorubicin—muscle cancer	9.28e-05	0.000808	CcSEcCtD
Quinidine—Headache—Doxorubicin—muscle cancer	9.23e-05	0.000804	CcSEcCtD
Quinidine—Nausea—Doxorubicin—muscle cancer	8.75e-05	0.000762	CcSEcCtD
